← Back to headlines
Halozyme Therapeutics Appoints Interim CFO Amid Growth Plans
Halozyme Therapeutics has announced the appointment of an interim Chief Financial Officer as the company continues to pursue its growth strategies.
29 Mar, 19:48 — 29 Mar, 19:48
Sources
Showing 1 of 1 sources
